KAUST and Janssen Pharmaceutical (Johnson & Johnson) are collaborating to research and innovate in neglected tropical diseases, focusing on dengue fever. They signed an MoU to establish a dengue fever research program and an infectious disease R&D center at KAUST's National BioPark. The partnership marks Johnson & Johnson's first university collaboration in Saudi Arabia. Why it matters: This collaboration signifies a major step in localizing disease research within Saudi Arabia and leveraging KAUST's AI, genomics, and data simulation expertise to address global health challenges.
KAUST researchers developed a new model integrating SIR compartment modeling in time and a point process modeling approach in space-time, also considering age-specific contact patterns. They used a two-step framework to model infectious locations over time for different age groups. The model demonstrated improved predictive accuracy in simulations and a COVID-19 case study in Cali, Colombia, compared to existing models. Why it matters: This model can assist decision-makers in identifying high-risk locations and vulnerable populations for better disease control strategies in the region and globally.
KAUST has launched the Smart-Health Initiative (SHI) to integrate smart technology into the Saudi healthcare system. The SHI aims to collaborate with hospitals and academic institutions to implement smart-health tools for disease prevention, diagnosis, and treatment. It focuses on precision medicine approaches for widespread diseases like metabolic syndrome disorders, genetic and infectious diseases. Why it matters: This initiative could modernize the Kingdom's healthcare system and promote personalized medicine by developing translational research programs and training clinicians in precision medicine.
KAUST professor David Ketcheson uses mathematical modeling to understand COVID-19 transmission. He applies differential equations to explain the progression of SARS-CoV-2, utilizing the SIR model to predict the spread. Ketcheson's analysis suggests that the reproduction number for COVID-19 could be as high as 5, emphasizing the need for social distancing. Why it matters: This highlights the role of mathematical modeling and data analysis in understanding and predicting the spread of infectious diseases, particularly in the context of pandemic response.
KAUST's Computational Bioscience Research Center (CBRC) and King Abdulaziz City for Science and Technology (KACST) have collaborated on research into methicillin-resistant Staphylococcus aureus (MRSA) within Saudi Arabia, starting in July 2018. The two-year project aims to understand MRSA drug resistance mechanisms specific to the Kingdom and its regions, with the goal of developing public health strategies. The project involves sequencing samples and performing bioinformatics analysis to support a network of researchers in the country. Why it matters: This initiative enhances Saudi Arabia's capacity to predict, prevent, and control infectious diseases, aligning with national health objectives and building local expertise in computational bioscience.
Malaria No More (MNM), Reaching the Last Mile (RLM), and MBZUAI have signed an agreement to expand the Forecasting Healthy Futures (FHF) initiative with a $5 million award from RLM. The initiative aims to address the impact of climate change on malaria and other climate-sensitive infectious diseases. MBZUAI will provide expertise to support the eradication of malaria. Why it matters: This partnership highlights the UAE's commitment to global health and leverages AI to combat climate-sensitive diseases, demonstrating a proactive approach to addressing complex global challenges.
Dr. Farida Al Hosani, a UAE public health leader and MBZUAI Executive Program graduate, has been at the forefront of the nation’s public health strategy, specializing in infectious diseases. She emphasizes the growing importance of AI in healthcare, particularly in areas like early detection, drug discovery, and public health strategies. Al Hosani has worked on several AI initiatives, including building algorithms and predictive modeling systems to bridge gaps in human health, especially in prevention. Why it matters: This highlights the increasing role of AI in transforming healthcare in the UAE, with public health leaders leveraging AI tools to improve disease prevention and treatment.